CN1086129C - Hepatitis restoration pill - Google Patents

Hepatitis restoration pill Download PDF

Info

Publication number
CN1086129C
CN1086129C CN99100650A CN99100650A CN1086129C CN 1086129 C CN1086129 C CN 1086129C CN 99100650 A CN99100650 A CN 99100650A CN 99100650 A CN99100650 A CN 99100650A CN 1086129 C CN1086129 C CN 1086129C
Authority
CN
China
Prior art keywords
hepatitis
radix
herba
medicine
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99100650A
Other languages
Chinese (zh)
Other versions
CN1231916A (en
Inventor
唐本善
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kang Tongding
Original Assignee
Kang Tongding
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kang Tongding filed Critical Kang Tongding
Priority to CN99100650A priority Critical patent/CN1086129C/en
Publication of CN1231916A publication Critical patent/CN1231916A/en
Application granted granted Critical
Publication of CN1086129C publication Critical patent/CN1086129C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a Chinese patent medicine for curing hepatitis, which relates to a hepatitis restoration pill and belongs to the medicine field. The present invention is mainly characterized in that the hepatitis restoration pill contains the medicines of oldenlandia, dandelion, lalang grass rhizome, bugleweed, common dayflower herb, common andrographis herb, finger citron, giant knotweed rhizome, liquorice roots, red sage roots, peach kernel, angelica, Chinese magnolivine fruit, aweto, milk vetch, Chinese data, notoginseng, ganoderma, bezoar, melanterite, etc. The present invention has the characteristics of good curative effect and high cure rate, and can be widely used for curing different hepatitis in clinic.

Description

A kind of medicine for the treatment of hepatitis
The present invention relates to a kind of Chinese patent medicine one hepatitis restoration pill for the treatment of hepatitis, belong to field of medicaments.
Hepatitis, the sickness rate height is one group of disease of serious harm human health.At present, the medicine of treatment hepatitis is a lot, waits bitterly for as interferon, anti-hepatitis B ribonucleic acid, the arabinose gland of Western medicine, and curative effect is low, easily recurrence, and toxic and side effects is big, costs an arm and a leg.Treatment by Chinese herbs hepatitis report to some extent in recent years, but effect is undesirable, relevant by retrieval document and Gazette of Patent for Invention, and not seeing has the same or analogous report with the present invention.
The object of the present invention is to provide and a kind ofly can effectively treat multiple hepatitis, cure rate height, taking convenience, Chinese patent medicine one hepatitis restoration pill without any side effects.
The present invention finishes by following technical scheme:
Described hepatitis restoration pill, its characteristics are to contain in this medicine medicines such as Herba Hedyotidis Diffusae, Herba Taraxaci, Rhizoma Imperatae, Spica Prunellae, Herba Commelinae, Herba Andrographis, Fructus Citri Sarcodactylis, Rhizoma Polygoni Cuspidati, Radix Glycyrrhizae, Radix Salviae Miltiorrhizae, Semen Persicae, Radix Angelicae Sinensis, Fructus Schisandrae Chinensis, Cordyceps, the Radix Astragali, Fructus Jujubae, Radix Notoginseng, Ganoderma, Calculus Bovis, Melanteritum.
Hepatitis restoration pill of the present invention, it is characterized in that its component by weight ratio (in the crude drug parts by weight) be: Herba Hedyotidis Diffusae 10-30 part Herba Taraxaci 10-30 part Rhizoma Imperatae 10-30 part Spica Prunellae 10-20 part Herba Commelinae 15-30 part Herba Andrographis 6-20 part Fructus Citri Sarcodactylis 5-15 part Rhizoma Polygoni Cuspidati 10-30 part Radix Glycyrrhizae 2-10 part Radix Salviae Miltiorrhizae 9-15 part Semen Persicae 6-10 part Radix Angelicae Sinensis 5-10 part Fructus Schisandrae Chinensis 3-12 part Cordyceps 3-10 part Radix Astragali 10-20 part Fructus Jujubae 10-35 part Radix Notoginseng 2-5 part Ganoderma 1.5-3 part Calculus Bovis 0.15-0.5 part Melanteritum 5-20 part.
Further specify the present invention below in conjunction with embodiment, but be not limited only to this.
Optimum implementation of the present invention:
Embodiment one:
1, the component of medicine and weight proportion thereof (in gram) are:
Herba Hedyotidis Diffusae 12g Herba Taraxaci 15g Rhizoma Imperatae 15g Spica Prunellae 10g Herba Commelinae 15g Herba Andrographis 9g Fructus Citri Sarcodactylis 5g Rhizoma Polygoni Cuspidati 15g Radix Glycyrrhizae 5g Radix Salviae Miltiorrhizae 12g Semen Persicae 6g Radix Angelicae Sinensis 9g Fructus Schisandrae Chinensis 3g Cordyceps 4g Radix Astragali 10g Fructus Jujubae 30g Radix Notoginseng 3g Ganoderma 2g Calculus Bovis 0.2g Melanteritum 10g
2, manufacture method:
With Herba Hedyotidis Diffusae; Herba Taraxaci; Rhizoma Imperatae; Spica Prunellae etc. 12 flavor Chinese medicines add that water is dense to be fried in shallow oil; mix twice fried liquid concentrated; get the dense juice A that fries in shallow oil; get Calculus Bovis; Radix Notoginseng; the Radix Astragali; Cordyceps; Radix Notoginseng; Ganoderma; Melanteritum 7 flavor Chinese medicine oven dry; be ground into fine powder B; to get and densely fry in shallow oil juice A and fine powder B stirs; be ground into superfine powder C after the oven dry, cross 100 mesh sieves and make powder D, the Fructus Jujubae water proof cooks the enucleation skin; smash into mud; with powder D mixing and stirring, sterile-processed after, make granular pill with granulating machine; the heavy 0.25g of every ball, patent medicine hepatitis restoration pill of the present invention.Certainly, those skilled in the art can be made for dosage forms such as pill, powder, sublimed preparation or capsule by the component of this Chinese patent medicine-hepatitis restoration pill, make things convenient for the patient to take.
3, drug administration method and preservation
For oral administration after meal, day clothes three times, each 0.25g~0.5g, 30 is a course of treatment, serve on 1~3 course of treatment.Medicine should place shady and cool dry place to preserve.
Embodiment two:
1, the component of medicine and weight proportion thereof (in gram) are:
Herba Hedyotidis Diffusae 15g Herba Taraxaci 15g Rhizoma Imperatae 20g Spica Prunellae 15g
Herba Commelinae 20g Herba Andrographis 12g Fructus Citri Sarcodactylis 10g Rhizoma Polygoni Cuspidati 20g
Radix Glycyrrhizae 5g Radix Salviae Miltiorrhizae 12g Semen Persicae 9g Radix Angelicae Sinensis 12g
Fructus Schisandrae Chinensis 9g Cordyceps 5g Radix Astragali 15g Fructus Jujubae 20g
Radix Notoginseng 3g Ganoderma 2g Calculus Bovis 0.3g Melanteritum 15g
2, the manufacture method of medicine, instructions of taking and store method are with embodiment one.
Embodiment three:
1, the component of medicine and weight proportion thereof (in gram) are:
Herba Hedyotidis Diffusae 30g Herba Taraxaci 30g Rhizoma Imperatae 30g Spica Prunellae 20g
Herba Commelinae 30g Herba Andrographis 20g Fructus Citri Sarcodactylis 15g Rhizoma Polygoni Cuspidati 30g
Radix Glycyrrhizae 10g Radix Salviae Miltiorrhizae 15g Semen Persicae 10g Radix Angelicae Sinensis 16g
Fructus Schisandrae Chinensis 12g Cordyceps 10g Radix Astragali 20g Fructus Jujubae 35g
Radix Notoginseng 5g Ganoderma 3g Calculus Bovis 0.5g Melanteritum 20g
2, the manufacture method of medicine, instructions of taking and store method are with embodiment one.
Above-mentioned three embodiment institute differences are to select according to the different state of an illness of patient, and the parts by weight that each medicine of distinguishing the flavor of is got differ, and make the stronger hepatitis restoration pill of various state of an illness specific aims.According to the various state of an illness, in described various prescriptions, can also add suitable leaf fat and Semen Tritici aestivi flour, utilize this prescription treatment hepatitis B to receive reasonable effect.
Chinese patent medicine-the hepatitis restoration pill of treatment hepatitis of the present invention is that the inventor is on the basis of secret prescription handed down in the family from generation to generation, consult a large amount of Gus, modern Chinese and foreign documents, to the treatment hepatopathy carry out repeated screening through the proved recipe medicine, and add through modern pharmacology and clinical research confirmation suppressing and removing hepatitis virus, adjust immune function of human body, recover liver form and function, control hepatic fibrosis and canceration truly have the Chinese medicine component of curative effect, concoct through science processing to form.
Through clinical observation, hepatitis restoration pill has strengthening body resistance and dispelling evil, adjusts the human immunologic function, effects such as inhibition and removing hepatitis virus, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling.After taking, remarkable to the hepatitis symptom control action, good effect, short treating period, instant effect, the cure rate height is difficult for recurrence, confirms that through clinical observation its effective percentage is 96%.Its course of treatment is the shortest to be 15 days, and patient's every index after treating all reaches arm's length standard, is one of optimal drug for the treatment of at present hepatitis.
According to incomplete statistics, from January 1,1 day to 1999 January in 1989, through 2000 routine hepatitis with hepatitis restoration pill for curing of the present invention, hepatitis A patient's 800 examples are treated recovery from illness 800 examples on the 15th, cure rate 100%.Hepatitis B patient 1000 examples, positive 1000 examples of HBSAg, 425 examples of turning out cloudy, negative conversion rate 42.5%; Positive 600 examples of HBeAg, 400 examples of turning out cloudy, negative conversion rate 66.6%; Unusual 500 examples of glutamate pyruvate transaminase (SGPT) are treated and were recovered normal 480 examples in month, account for 96%.Hepatitis sx or disappearance person account for 98%.
Attached model case:
(1) king so-and-so, the man, 32 years old, chemical plant, Puyang County worker, first visit on May 20 in 1989 is an acute icterohepatitisshock, HBSAg, HBeAg, anti--three positives of HBC, GBT-360u, TTT-18u, icteric index 39.Through taking the hepatitis restoration pill for curing, on June 10th, 89 checked, and HBeAg turns out cloudy, GBT, and TTT, the icteric index full recovery is normal.Continue clothes to check on July 10th, 89, HBSAg, anti--HBC turns out cloudy, and is anti--the HBS positive.Stable curative effect, once repeatedly check was anti--the HBS positive, did not see recurrence so far.
(2) Lee so-and-so, the man, 46 years old, the cadre of Jiaozuo City agricultural bank suffered from hepatitis B 4 years, once used interferon therapy three months invalid.The first visit in 20, of 96 on JIUYUE is a great three positive, and through taking the hepatitis restoration pill for curing one month, HBeAg turns out cloudy, and treats three checks course of treatment, HBSAg, and anti--HBC turns out cloudy, and is anti--the HBS positive, do not see recurrence so far.
(3) Liu so-and-so, woman, 52 years old, Dongming, Shandong Province county three spring months township peasant suffered from hepatitis B 8 years, and first visit on March 5 in 92 year is a great three positive, B ultrasonic shows cirrhotic ascites, through taking the check in three months of hepatitis restoration pill for curing, HBSAg, HBeAg turns out cloudy, anti--HBC turns out cloudy, and is anti--the HBS positive, and B ultrasonic shows that the liver form is normal substantially, no ascites is not seen recurrence so far.

Claims (4)

1. medicine for the treatment of hepatitis is characterized in that it mainly being that raw material by following weight portion is made: Herba Hedyotidis Diffusae 10-30 part, Herba Taraxaci 10-30 part; Rhizoma Imperatae 10-30 part; Spica Prunellae 10-20 part, Herba Commelinae 15-30 part, Herba Andrographis 6-20 part; Fructus Citri Sarcodactylis 5-15 part; Rhizoma Polygoni Cuspidati 10-30 part, Radix Glycyrrhizae 2-10 part, Radix Salviae Miltiorrhizae 9-15 part; Semen Persicae 6-10 part; Radix Angelicae Sinensis 5-10 part, Fructus Schisandrae Chinensis 3-12 part, Cordyceps 3-10 part; Radix Astragali 10-20 part; Fructus Jujubae 10-35 part, Radix Notoginseng 2-5 part, Ganoderma 1.5-3 part; Calculus Bovis 0.15-0.5 part, Melanteritum 5-20 part.
2. medicine as claimed in claim 1 is characterized in that it mainly being that raw material by following row weight portion is made: Herba Hedyotidis Diffusae 12g, Herba Taraxaci 15g, Rhizoma Imperatae 15g; Spica Prunellae 10g, Herba Commelinae 15g, Herba Andrographis 9g, Fructus Citri Sarcodactylis 5g; Rhizoma Polygoni Cuspidati 15g, Radix Glycyrrhizae 5g, Radix Salviae Miltiorrhizae 12g, Semen Persicae 6g; Radix Angelicae Sinensis 9g, Fructus Schisandrae Chinensis 3g, Cordyceps 4g; Radix Astragali 10g, Fructus Jujubae 30g, Radix Notoginseng 3g; Ganoderma 2g, Calculus Bovis 0.2g, Melanteritum 10g.
3. medicine as claimed in claim 1 or 2 is characterized in that it is pill, powder, sublimed preparation or capsule.
4. as any one described medicine of claim 1-3, it is characterized in that it also contains leaf fat and wheat flour.
CN99100650A 1999-02-11 1999-02-11 Hepatitis restoration pill Expired - Fee Related CN1086129C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99100650A CN1086129C (en) 1999-02-11 1999-02-11 Hepatitis restoration pill

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99100650A CN1086129C (en) 1999-02-11 1999-02-11 Hepatitis restoration pill

Publications (2)

Publication Number Publication Date
CN1231916A CN1231916A (en) 1999-10-20
CN1086129C true CN1086129C (en) 2002-06-12

Family

ID=5270123

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99100650A Expired - Fee Related CN1086129C (en) 1999-02-11 1999-02-11 Hepatitis restoration pill

Country Status (1)

Country Link
CN (1) CN1086129C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1086300C (en) * 1999-11-05 2002-06-19 汪怀元 Prescription for treating hepatism
CN1318050C (en) * 2002-06-10 2007-05-30 谢邦和 Chinese medicine for treating heaptitis B and preparation method thereof and use of charred human hair
CN100337658C (en) * 2005-06-09 2007-09-19 北京四环科宝制药有限公司 Chinese medicine composition for treating cold anemopyretic syndrome, and its preparing method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1171257A (en) * 1996-07-19 1998-01-28 郑先兵 Chinese-herbal medicine for curing hepatitis B and its preparing process
CN1176123A (en) * 1996-02-15 1998-03-18 邵阳县中医院 Medicine for chronic hepatitis B and its preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1176123A (en) * 1996-02-15 1998-03-18 邵阳县中医院 Medicine for chronic hepatitis B and its preparation
CN1171257A (en) * 1996-07-19 1998-01-28 郑先兵 Chinese-herbal medicine for curing hepatitis B and its preparing process

Also Published As

Publication number Publication date
CN1231916A (en) 1999-10-20

Similar Documents

Publication Publication Date Title
CN1044974C (en) Anti- hepatitis B preparation
CN1255181C (en) Preparation of medicinal composition for nourishing
CN1245173C (en) Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process
CN1539441A (en) Compounded medicine for anti pathogeny and immunoenhancement
CN1056755C (en) Medicine of curing hepatitis
CN1063954C (en) Chinese patent medicine-powder preparation for curing hepatitis B
CN1086129C (en) Hepatitis restoration pill
CN1243743A (en) Medicine for treating chronic hepatism and its preparing process
CN1298362C (en) Compound Chinese medicine prepn for treating pulvic infection and its prepn process
CN1052889C (en) Chinese proprietary for curing hepatitis
CN1171615C (en) Chinese medicine prepn for treating fatty liver and obesity
CN1066628C (en) Medicine for chronic hepatitis B and its preparation
CN101036779A (en) Composite medicine for treating hepatopathy and its preparing process
CN1060379C (en) Chines medicine for treating vitiligo and preparation method thereof
CN1903276A (en) Medicinal composition for treating hepatitis B
CN1217204A (en) Medicine for nourishing muscle and recovering physical strength, and preparation method therefor
CN1453014A (en) Chinese medicine prepn for preventing fibrillated liver and treating hepatocirrhosis
CN1136939A (en) Chinese drugs for curing hepatitis B
CN1195541C (en) Medicine combination for treating chronic hepatitis B
CN1130529A (en) Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof
CN1253017A (en) Medicine for treating appendicitis
CN1286483C (en) Chinese traditional drug pills capable of protecting liver, resisting hepatic fibrosis and expelling toxins
CN1179953A (en) Complete set of Chinese medicine preparations for curing hepatitis B
CN1814250A (en) Chinese medicine composition for treating liver cirrhosis ascites and use thereof
CN1340353A (en) Orally-applied medicine for treating hepatism and its preparing process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee